Lam, Max http://orcid.org/0000-0002-4256-7844
,
Chen, Chia-Yen
Li, Zhiqiang http://orcid.org/0000-0002-0174-9254
Martin, Alicia R. http://orcid.org/0000-0003-0241-3522
Bryois, Julien http://orcid.org/0000-0002-4747-2166
Ma, Xixian
Gaspar, Helena http://orcid.org/0000-0002-5540-2707
Ikeda, Masashi
Benyamin, Beben http://orcid.org/0000-0001-5608-2293
Brown, Brielin C.
Liu, Ruize
Zhou, Wei
Guan, Lili
Kamatani, Yoichiro http://orcid.org/0000-0001-8748-5597
Kim, Sung-Wan
Kubo, Michiaki
Kusumawardhani, Agung A. A. A.
Liu, Chih-Min http://orcid.org/0000-0001-7016-8990
Ma, Hong
Periyasamy, Sathish http://orcid.org/0000-0002-8132-5717
Takahashi, Atsushi http://orcid.org/0000-0001-7099-8767
Xu, Zhida
Yu, Hao http://orcid.org/0000-0002-9785-8489
Zhu, Feng
Chen, Wei J.
Faraone, Stephen
Glatt, Stephen J.
He, Lin
Hyman, Steven E.
Hwu, Hai-Gwo
McCarroll, Steven A.
Neale, Benjamin M.
Sklar, Pamela
Wildenauer, Dieter B.
Yu, Xin
Zhang, Dai
Mowry, Bryan J.
Lee, Jimmy
Holmans, Peter
Xu, Shuhua
Sullivan, Patrick F.
Ripke, Stephan
O’Donovan, Michael C.
Daly, Mark J.
Qin, Shengying
Sham, Pak
Iwata, Nakao
Hong, Kyung S.
Schwab, Sibylle G. http://orcid.org/0000-0002-9370-9080
Yue, Weihua
Tsuang, Ming
Liu, Jianjun
Ma, Xiancang
Kahn, René S.
Shi, Yongyong
Huang, Hailiang
,
,
Article History
Received: 9 January 2019
Accepted: 10 September 2019
First Online: 18 November 2019
Competing interests
: B.M.N. is a member of the Deep Genomics Scientific Advisory Board. He also serves as a consultant for the Camp4 Therapeutics Corporation, Takeda Pharmaceutical and Biogen. M.J.D. is a founder of Maze Therapeutics. The remaining authors declare no competing interests.